In isolation, our IL-15 and ALDH1A2 data would argue against the potential for hookworm infection to protect against gluten toxicity in celiac disease, the primary incentive for undertaking this clinical trial [21], [22]. The gene discussed is ALDH1A2; the disease is ancylostomiasis.